Movement disorders News and Research

RSS

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

27 Jan 2021

NIH awards $5.59 million research grants to prevent and treat cerebral palsy

The National Institutes of Health is supporting a Wayne State University School of Medicine physician-researcher's work at preventing and treating cerebral palsy in the form of two new five-year R01 grants worth a collective $5.59 million.

27 Jan 2021

Medicinal cannabis improves outcomes in Parkinson's patients

With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD).

27 Jan 2021

Simple vision tests can predict Parkinson's dementia before it begins

Simple vision tests can predict which people with Parkinson's disease will develop cognitive impairment and possible dementia 18 months later, according to a new study by UCL researchers.

19 Jan 2021

New nasal spray delivers antipsychotic medication directly to the brain

A team of neuroscientists and engineers at McMaster University has created a nasal spray to deliver antipsychotic medication directly to the brain instead of having it pass through the body.

16 Jan 2021

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown.

7 Jan 2021

Simple skin test can accurately identify Parkinson's disease, research shows

New research shows a simple skin test can accurately identify Parkinson's disease, demonstrating for the first time the feasibility of the method.

21 Oct 2020

Dopamine and serotonin play role in perception and decision-making

Scientists at Wake Forest School of Medicine have recorded real time changes in dopamine and serotonin levels in the human brain that are involved with perception and decision-making.

12 Oct 2020

UC Davis School of Medicine and UTHealth receive NIH grant for dementia research

A team of brain scientists from UC Davis School of Medicine and The University of Texas Health Science Center at Houston has been awarded a six-year grant expected to total $53.6 million from the National Institutes of Health.

7 Oct 2020

NIH awards $3.8 million to predict dementia in patients with Parkinson's disease

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health has awarded a grant expected to total $3.8 million to Virendra Mishra, Ph.D., associate staff at Cleveland Clinic Lou Ruvo Center for Brain Health, to identify biomarkers - or disease indicators - to predict dementia in patients with Parkinson's disease.

6 Oct 2020

Parkinson's disease is an independent risk factor for dying from COVID-19, study suggests

A new study of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30% higher risk of dying from COVID-19 than people without the neurodegenerative condition.

1 Oct 2020

Translational research training program helps students to better understand patients' problems

Translational research aims to speed research breakthroughs into the clinic. And yet, training for basic scientists and clinicians too often remains siloed, leading to divergent cultures and a loss of opportunity for cross-disciplinary collaboration.

26 Sep 2020

Experts review common and vexing issues affecting people with Parkinson's disease

Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society.

24 Sep 2020

Existence of brain-first and body-first Parkinson’s disease subtypes

Although the name may suggest otherwise, Parkinson's disease is not one but two diseases, starting either in the brain or in the intestines.

22 Sep 2020

Physical exercise protocol can mitigate the severity of Parkinson's disease

Freezing of gait, one of the most incapacitating symptoms of Parkinson's disease, manifests as sudden, short episodes of an inability to move the feet forward despite the intention to walk.

16 Sep 2020

Parkinson's disease drug may improve vision in patients with age-related macular degeneration

Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision.

10 Sep 2020

Diabetes linked to increased risk of Parkinson’s

New research funded by Parkinson’s UK has identified further evidence that diabetes may increase risk of Parkinson's.

13 Aug 2020

Experts debate over future Parkinson’s disease trial involving growth factors

Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson's disease (PD), but trials have been disappointing.

5 Jun 2020

CBD treatment improves arthritis symptoms in dogs, study finds

A team led by researchers at Baylor College of Medicine in collaboration with Medterra CBD conducted the first scientific studies to assess the potential therapeutic effects of cannabidiol for arthritic pain in dogs, and the results could lead the way to studying its effect in humans.

28 May 2020

UCLA study shows link between diesel exhaust and risk of Parkinson's

A new UCLA study in zebrafish has identified the process by which air pollution can damage brain cells, potentially contributing to Parkinson's disease.

20 May 2020